Specialty Pharmacy Times announces the addition of a new department, Oncology Trends. This section will focus on the management of oncology medications under the pharmacy and medical benefits, clinical pathways, pharmacogenomic and companion testing, and clinical practice guidelines in oncology.
The utilization of biologics for rheumatoid arthritis and the management of the condition by specialty pharmacies are examined in 2 new studies from The American Journal of Pharmacy Benefits and The American Journal of Managed Care.
A newly reintroduced bipartisan bill called the Patient Access to Treatments Act 2013 seeks to help eliminate specialty tiers in commercial health insurance plans.
